These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11012904)

  • 1. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
    Festa A; D'Agostino R; Howard G; Mykkänen L; Tracy RP; Haffner SM
    Kidney Int; 2000 Oct; 58(4):1703-10. PubMed ID: 11012904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of body fat mass and distribution to markers of chronic inflammation.
    Festa A; D'Agostino R; Williams K; Karter AJ; Mayer-Davis EJ; Tracy RP; Haffner SM
    Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1407-15. PubMed ID: 11673759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute-phase proteins and microalbuminuria among patients with type 2 diabetes.
    Gomes MB; Nogueira VG
    Diabetes Res Clin Pract; 2004 Oct; 66(1):31-9. PubMed ID: 15364159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
    Festa A; D'Agostino R; Tracy RP; Haffner SM;
    Diabetes; 2002 Apr; 51(4):1131-7. PubMed ID: 11916936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria.
    Park SE; Kim WJ; Park SW; Park JW; Lee N; Park CY; Youn BS
    Eur J Endocrinol; 2013 Feb; 168(2):203-10. PubMed ID: 23144053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
    Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I
    Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).
    Festa A; D'Agostino R; Howard G; Mykkänen L; Tracy RP; Haffner SM
    Circulation; 2000 Jul; 102(1):42-7. PubMed ID: 10880413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria.
    Makino H; Doi K; Hiuge A; Nagumo A; Okada S; Miyamoto Y; Suzuki M; Yoshimasa Y
    Diabetes Res Clin Pract; 2008 Jan; 79(1):177-82. PubMed ID: 17904244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women?
    Halimi JM; Forhan A; Balkau B; Novak M; Wilpart E; Tichet J; Marre M;
    J Cardiovasc Risk; 2001 Jun; 8(3):139-46. PubMed ID: 11455845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.
    Lu B; Wen J; Song XY; Dong XH; Yang YH; Zhang ZY; Zhao NQ; Ye HY; Mou B; Chen FL; Liu Y; Shen Y; Wang XC; Zhou LN; Li YM; Zhu XX; Hu RM
    Diabetes Res Clin Pract; 2007 Feb; 75(2):184-92. PubMed ID: 16893584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in L-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria.
    Bariş N; Erdoğan M; Sezer E; Saygili F; Mert Ozgönül A; Turgan N; Ersöz B
    Acta Diabetol; 2009 Dec; 46(4):309-16. PubMed ID: 19183843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.
    Streja D; Cressey P; Rabkin SW
    J Diabetes Complications; 2003; 17(3):120-7. PubMed ID: 12738395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study.
    Tsioufis C; Dimitriadis K; Andrikou E; Thomopoulos C; Tsiachris D; Stefanadi E; Mihas C; Miliou A; Papademetriou V; Stefanadis C
    Am J Kidney Dis; 2010 Jun; 55(6):1050-9. PubMed ID: 20189274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
    Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
    Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group.
    Agewall S; Fagerberg B; Attvall S; Ljungman S; Urbanavicius V; Tengborn L; Wikstrand J
    J Intern Med; 1995 Feb; 237(2):195-203. PubMed ID: 7852923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent impact of glycemia and blood pressure in albuminuria on high-risk subjects for metabolic syndrome.
    Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
    Clin Nephrol; 2004 Jun; 61(6):369-76. PubMed ID: 15224799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.